SCHEMBL2409808

SCHEMBL2409808

CCOc1ccc(C(=C[C@H]2CCC(=O)N2)c2ccc(C3CC3)c(OC)n2)cc1Cl

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 10/20 0.33
PDCD1 Q15116 3/20 0.33
IRAK1 P51617 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
NPC1 O15118 2/20 0.33
MAPT P10636 2/20 0.33
RAB9A P51151 2/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
PDCD1LG2 Q9BQ51 7/20 0.32
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
GAA P10253 2/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2412907 1.00 CD274 (0.33) CD274PDCD1IRAK1IRAK4SMN1; SMN2
SCHEMBL2409805 1.00 CD274 (0.33) CD274PDCD1IRAK1IRAK4SMN1; SMN2
SCHEMBL2413492 0.92 TAS1R3 (0.37) CD274PDCD1IRAK4MAPTTP53
SCHEMBL2413495 0.92 TAS1R3 (0.37) CD274PDCD1IRAK4MAPTTP53
SCHEMBL2411230 0.92 SMN1; SMN2 (0.35) CD274PDCD1IRAK1IRAK4SMN1; SMN2
SCHEMBL2416397 0.92 SMN1; SMN2 (0.35) CD274PDCD1IRAK1IRAK4SMN1; SMN2
SCHEMBL2411228 0.92 SMN1; SMN2 (0.35) CD274PDCD1IRAK1IRAK4SMN1; SMN2
SCHEMBL2416808 0.90 PDE4A (0.36) CD274PDCD1IRAK1IRAK4PDCD1LG2
SCHEMBL2416810 0.90 PDE4A (0.36) CD274PDCD1IRAK1IRAK4PDCD1LG2
SCHEMBL2411289 0.89 CD274 (0.33) CD274PDCD1PDCD1LG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822503-B2 2-pyridone compounds TAISHO PHARMACEUTICAL CO., LTD (JP) 2014-09-02 US disclosed
CN-102884047-A 2-pyridone compounds TAISHO PHARMACEUTICAL CO LTD 2013-01-16 CN disclosed
EP-2508513-A1 2-PYRIDONE COMPOUNDS Taisho Pharmaceutical Co., Ltd. (JP) 2012-10-10 EP disclosed
US-20110237791-A1 2-PYRIDONE COMPOUNDS TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237791-A1 2-PYRIDONE COMPOUNDS PDXK, HK1, KCNJ2 CD274 2673/4885PDCD1 1388/4885IRAK1 593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.